You just read:

ARMGO Pharma Receives FDA Orphan Drug Designation for ARM210/S48168 for the Treatment of Ryanodine Receptor Type 1 Related Myopathies

News provided by

ARMGO Pharma, Inc.

Sep 05, 2018, 10:22 ET